Etomidate and ketamine are frequently used for RSI in critically ill patients. Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI. Notwithstanding, is either agent superior for RSI in the critically ill? In this podcast we discuss the recently published EvK trial, which evaluated etomidate and ketamine for RSI in emergency endotracheal intubations.
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
In 2017, Paul Marik published a single-center retrospective before-and-after study that demonstrated significant mortality benefit to patients with septic shock who received a cocktail...
The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial...
Mechanically ventilating the patient with a severe asthma exacerbation is fraught with peril. Incorrect settings for tidal volume, respiratory rate, pressure triggers, or inspiratory...